35th Ernst Klenk Symposium in Molecular Medicine. Rare diseases: From mechanisms to therapy and beyond. September 15 - 17, 2019 in Cologne

35th Ernst Klenk Symposium in Molecular Medicine


It is our great pleasure to announce the 35th Ernst Klenk Symposium in Molecular Medicine 2019 on "Rare diseases: From mechanisms to therapy and beyond".

We are also honored to anounce that Professor Arthur H M Burghes (The Ohio State University Wexner Medical Center, Columbus - US) has accepted our invitation as scientific coordinator and as honorary guest speaker for the Klenk Lecture. Thanks to the outstanding support of Professor Burghes we succeeded to setup and to present a scientific program with international leading experts in the research field of rare diseases and therapy. We are delighted that following experts confirmed their participation as guest speakers in the following sessions:

State of the art in rare disease discovery: Clara D M van Karnebeek (Amsterdam, NL) - William A Gahl (Bethesda, US) - Georg F Hoffmann (Heidelberg, DE)

Technologies to understand functional impact of human variation causing rare diseases: Lea M Starita (Seattle, US) - Joseph V Bonventre (Boston, US) - Ron A Wevers (Nijmegen, NL)

Small molecule based  therapy in neurological disorders: Frank C Bennet (Carlsbad, US) - Richard S Finkel (Orlando, US) - Nicholas Katsanis (Berlin, DE)

Gene therapy to treat rare disorders: Luk H Vandenberghe (Cambridge, US) - Barry Byrne (Dublin, IE) - Hélène Puccio (Illkirch, FR)

Rare kidney and endocrine disorders and therapy: Heiko Krude (Berlin, DE) - Vicente E Torres (Rochester, US) - Pierre Ronco (Paris, FR)

Cancer and rare immune-mediated disease therapy and regulation: Michael R Speicher (Graz, AT) - Marie Scully (London, UK) - Marco Cavaleri (London, UK)

Metabolic disorders and therapy: Frances Platt (Oxford, UK) - Carmine Settembre (Pozzuoli-Napoli, IT)

Muscle, bone and dermis genetic disorders - from mechanism to treatment
Frank Rauch
(Montreal, CA) - Holm Schneider (Erlangen, DE)

What's next:
Sir John Burn (Newcastle upon Tyne, UK)

Information for the submission of poster abstracts for the poster session including the poster award will be available soon.

The participation in the Klenk Symposium is free of charge. Online registration will be available soon.

Cologne Klenk Symposium Board 2019

Chairs: Brunhilde Wirth - Guenter Schwarz
Oliver Cornely - Jörg Dötsch - Roman-Ulrich Müller - Christian Schaaf - Bernhard Schermer - Michal-Ruth Schweiger - Thomas Benzing (Chair - CMMC) - Debora Grosskopf-Kroiher (CMMC-Organization)

Our Partners

CECAD Cologne - Cluster of ExcellenceCRU 329CRC 829 FOR 2240CRC 1218 KFO 286 • Clinical Trials Centre Cologne (ZKS Köln)SybacolCologne Center for Genomics • Center for Integrated Oncology • Institute for Human Genetics • Dept. for Biochemistry • Dept. I for Internal Medicine • Dept. II for Internal Medicine • University Hospital Cologne • ORPHEUS • BioRiver - Life Science im Rheinland e.V. • Cologne Convention Bureau


Center for Molecular Medicine Cologne (CMMC) - University of Cologne

The CMMC organizers thank the Cologne Convention Bureau for their excellent support.
Further information: http://www.conventioncologne.de


We expect a lively meeting, which allows a rewarding exchange among colleagues working in the field of “Rare diseases: From mechanisms to therapies and beyond”.

We are looking forward to welcoming you.

With best regards

Brunhilde Wirth and Guenter Schwarz
Chairs of the Cologne Klenk Symposium Committee 2019

Klenk Poster 2019